Literature DB >> 26958278

Handling Temporality of Clinical Events for Drug Safety Surveillance.

Jing Zhao1, Aron Henriksson1, Maria Kvist2, Lars Asker1, Henrik Boström1.   

Abstract

Using longitudinal data in electronic health records (EHRs) for post-marketing adverse drug event (ADE) detection allows for monitoring patients throughout their medical history. Machine learning methods have been shown to be efficient and effective in screening health records and detecting ADEs. How best to exploit historical data, as encoded by clinical events in EHRs is, however, not very well understood. In this study, three strategies for handling temporality of clinical events are proposed and evaluated using an EHR database from Stockholm, Sweden. The random forest learning algorithm is applied to predict fourteen ADEs using clinical events collected from different lengths of patient history. The results show that, in general, including longer patient history leads to improved predictive performance, and that assigning weights to events according to time distance from the ADE yields the biggest improvement.

Entities:  

Mesh:

Year:  2015        PMID: 26958278      PMCID: PMC4765556     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  11 in total

1.  Adverse drug reactions as a cause for admissions to a department of internal medicine.

Authors:  Tom Mjörndal; Marit Danell Boman; Staffan Hägg; Martin Bäckström; Bengt-Erik Wiholm; Anders Wahlin; Rune Dahlqvist
Journal:  Pharmacoepidemiol Drug Saf       Date:  2002 Jan-Feb       Impact factor: 2.890

2.  A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions.

Authors:  Eugène P van Puijenbroek; Andrew Bate; Hubert G M Leufkens; Marie Lindquist; Roland Orre; Antoine C G Egberts
Journal:  Pharmacoepidemiol Drug Saf       Date:  2002 Jan-Feb       Impact factor: 2.890

3.  Dose-specific adverse drug reaction identification in electronic patient records: temporal data mining in an inpatient psychiatric population.

Authors:  Robert Eriksson; Thomas Werge; Lars Juhl Jensen; Søren Brunak
Journal:  Drug Saf       Date:  2014-04       Impact factor: 5.606

4.  Rofecoxib (Vioxx) voluntarily withdrawn from market.

Authors:  Barbara Sibbald
Journal:  CMAJ       Date:  2004-10-26       Impact factor: 8.262

5.  'Global trigger tool' shows that adverse events in hospitals may be ten times greater than previously measured.

Authors:  David C Classen; Roger Resar; Frances Griffin; Frank Federico; Terri Frankel; Nancy Kimmel; John C Whittington; Allan Frankel; Andrew Seger; Brent C James
Journal:  Health Aff (Millwood)       Date:  2011-04       Impact factor: 6.301

6.  Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study.

Authors:  Sebastian Schneeweiss; Joerg Hasford; Martin Göttler; Annemarie Hoffmann; Ann-Kathrin Riethling; Jerry Avorn
Journal:  Eur J Clin Pharmacol       Date:  2002-06-12       Impact factor: 2.953

7.  Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients.

Authors:  Munir Pirmohamed; Sally James; Shaun Meakin; Chris Green; Andrew K Scott; Thomas J Walley; Keith Farrar; B Kevin Park; Alasdair M Breckenridge
Journal:  BMJ       Date:  2004-07-03

8.  Using electronic health care records for drug safety signal detection: a comparative evaluation of statistical methods.

Authors:  Martijn J Schuemie; Preciosa M Coloma; Huub Straatman; Ron M C Herings; Gianluca Trifirò; Justin Neil Matthews; David Prieto-Merino; Mariam Molokhia; Lars Pedersen; Rosa Gini; Francesco Innocenti; Giampiero Mazzaglia; Gino Picelli; Lorenza Scotti; Johan van der Lei; Miriam C J M Sturkenboom
Journal:  Med Care       Date:  2012-10       Impact factor: 2.983

9.  Drug-related admissions and hospital-acquired adverse drug events in Germany: a longitudinal analysis from 2003 to 2007 of ICD-10-coded routine data.

Authors:  Jürgen Stausberg; Joerg Hasford
Journal:  BMC Health Serv Res       Date:  2011-05-29       Impact factor: 2.655

10.  Withdrawal of cerivastatin from the world market.

Authors:  Curt D Furberg; Bertram Pitt
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001
View more
  6 in total

1.  Evaluation of Electronic Healthcare Databases for Post-Marketing Drug Safety Surveillance and Pharmacoepidemiology in China.

Authors:  Yu Yang; Xiaofeng Zhou; Shuangqing Gao; Hongbo Lin; Yanming Xie; Yuji Feng; Kui Huang; Siyan Zhan
Journal:  Drug Saf       Date:  2018-01       Impact factor: 5.606

2.  Artificial Intelligence in Pharmacoepidemiology: A Systematic Review. Part 1-Overview of Knowledge Discovery Techniques in Artificial Intelligence.

Authors:  Maurizio Sessa; Abdul Rauf Khan; David Liang; Morten Andersen; Murat Kulahci
Journal:  Front Pharmacol       Date:  2020-07-16       Impact factor: 5.810

3.  A classification framework for exploiting sparse multi-variate temporal features with application to adverse drug event detection in medical records.

Authors:  Francesco Bagattini; Isak Karlsson; Jonathan Rebane; Panagiotis Papapetrou
Journal:  BMC Med Inform Decis Mak       Date:  2019-01-10       Impact factor: 2.796

4.  Informative presence and observation in routine health data: A review of methodology for clinical risk prediction.

Authors:  Rose Sisk; Lijing Lin; Matthew Sperrin; Jessica K Barrett; Brian Tom; Karla Diaz-Ordaz; Niels Peek; Glen P Martin
Journal:  J Am Med Inform Assoc       Date:  2021-01-15       Impact factor: 4.497

5.  Ensembles of randomized trees using diverse distributed representations of clinical events.

Authors:  Aron Henriksson; Jing Zhao; Hercules Dalianis; Henrik Boström
Journal:  BMC Med Inform Decis Mak       Date:  2016-07-21       Impact factor: 2.796

6.  Learning temporal weights of clinical events using variable importance.

Authors:  Jing Zhao; Aron Henriksson
Journal:  BMC Med Inform Decis Mak       Date:  2016-07-21       Impact factor: 2.796

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.